ÂÜÀòÂÒÂ×

Mihnea Morar is a business development analyst at Medexus Pharmaceuticals since June 2023, following a tenure as a healthcare equity analyst at Desautels Capital Management from June 2022 to April 2023. Prior experience includes a role as an undergraduate research assistant at Schulich School of Medicine & Dentistry from September 2019 to January 2020. Mihnea holds a Master of Management in Finance (MMF) from McGill University - Desautels Faculty of Management, obtained in October 2023, and a Bachelor of Medical Sciences (BMSc) in Interdisciplinary Medical Sciences from Western University, completed in April 2022.